QUADRANT CAPITAL GROUP LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 1 filers reported holding ANI PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$697
+7.9%
120.0%0.00%
Q2 2023$646
+35.4%
120.0%0.00%
Q1 2023$477
-50.6%
12
-50.0%
0.00%
Q4 2022$966
-3.4%
24
-20.0%
0.00%
Q3 2022$1,0000.0%30
-30.2%
0.00%
Q2 2022$1,0000.0%43
+48.3%
0.00%
Q1 2022$1,000
-50.0%
29
-43.1%
0.00%
Q4 2021$2,000
+100.0%
51
+96.2%
0.00%
Q3 2021$1,000260.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders